- Home
- RGC vs GMED Comparison
RGC vs GMED Comparison
Compare RGC & GMED Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RGC | GMED |
|---|---|---|
| Founded | 2014 | 2003 |
| Country | Hong Kong | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.5B | 12.9B |
| IPO Year | 2020 | 2012 |
Fundamental Metrics
Financial Performance| Metric | RGC | GMED |
|---|---|---|
| Price | $23.08 | $84.77 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 14 |
| Target Price | N/A | ★ $100.42 |
| AVG Volume (30 Days) | 104.8K | ★ 963.6K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 422.67 |
| EPS | N/A | ★ 3.92 |
| Revenue | N/A | ★ $2,938,931,000.00 |
| Revenue This Year | N/A | $10.72 |
| Revenue Next Year | N/A | $6.45 |
| P/E Ratio | ★ N/A | $21.57 |
| Revenue Growth | N/A | ★ 16.65 |
| 52 Week Low | $9.39 | $51.79 |
| 52 Week High | $950.00 | $101.40 |
Technical Indicators
Market Signals| Indicator | RGC | GMED |
|---|---|---|
| Relative Strength Index (RSI) | 41.77 | 36.37 |
| Support Level | $20.81 | $57.74 |
| Resistance Level | $26.42 | $87.16 |
| Average True Range (ATR) | 2.17 | 2.78 |
| MACD | -0.31 | -0.89 |
| Stochastic Oscillator | 19.38 | 2.80 |
Price Performance
Historical ComparisonAbout RGC Regencell Bioscience Holdings Limited
Regencell Bioscience Holdings Ltd is a bioscience company focusing on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degenerations, specifically ADHD and ASD, and infectious diseases affecting people's immune systems.
About GMED Globus Medical Inc.
Globus Medical Inc is a medical device company that develops and provides healthcare products and solutions to hospitals, physicians, and surgical centers. The firm's products are organized into two categories: musculoskeletal solutions, which include medical devices and instruments used mostly for spinal and orthopedic procedures, and enabling technologies, which include computer systems developed for enhancing surgical capabilities. The vast majority of the company's revenue is generated from musculoskeletal solutions products, and more than half of the revenue is earned in the United States. It also has its presence internationally.